Pharaoh Neuro has announced that the US Food and Drug Administration has granted Breakthrough Device designation to its ...
As the topic of radiation safety across various interventional specialties continues to garner increased interest, Melissa ...
Resolve Therapeutics has announced two e-posters featuring preclinical data on its RNase-Fc fusion protein RSLV-132, and its ...
The European Society of Minimally Invasive Neurological Therapy (ESMINT) has welcomed five additional national societies to ...
On World Stroke Day 2026 (29 October), the European Society of Minimally Invasive Neurological Therapy (ESMINT) has called for sustained investment in education, research, and stroke services.
The UK government has confirmed that it will continue to accept CE marked medical devices on a long-term basis, meaning ...
Von Vascular has announced the publication of a preclinical study evaluating its Algo smart pump with adaptive pulsatile ...
The Shenzhen Institute of Advanced Biomedical Robot (Abrobo)—through close medical-engineering collaboration with Jianmin Liu ...
Brainomix and Remedy Pharmaceuticals have announced “promising new findings” from a post-hoc analysis of the Phase 3 CHARM trial. Presented at last week’s World... Late-breaking research presented at ...
526 Fulham Road, Fulham, London, SW6 5NR TEL:+44 (0)20 7736 8788 ...
Phagenesis today announced that the US Food and Drug Administration (FDA) has granted a de novo request for the Phagenyx neurostimulation system, which uses pharyngeal electrical stimulation (PES) to ...
Ability Neurotech has announced the first-in-human procedure for its brain-computer interface (BCI) technology. Conducted at the Department of Neurosurgery at the Technical University of Munich’s (TUM ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results